Table 2.
OnabotulinumtoxinA dosage during baseline and combination treatment.
|
Baseline (N = 148) |
1st onabotA injection post-index (N = 127) |
2nd onabotA injection visit post-index (N = 96) |
3rd onabotA injection visit post-index (N = 73) |
4th onabotA injection visit post-index (N = 45) |
|
|---|---|---|---|---|---|
| Follow up (days) a | |||||
| Mean (SD) | - | 61.4 (29.0) | 89.3 (9.3) | 92.3 (16.6) | 91.0 (17.6) |
| Median (range) | - | 62 (7–155) | 86 (61–121) | 87.5 (40–168) | 84.5 (60–168) |
| OnabotulinumtoxinA dose (U) | |||||
| Mean (SD) | 166.6 (16.7) | 166.5 (16.8) | 165.3 (17.3) | 167.0 (17.0) | 166.1 (15.8) |
| Median (range) | 155 (125–200) | 155 (125–200) | 155 (120–200) | 165 (125–200) | 165 (125–200) |
| Unknown | 2 (2.7) | ||||
onabotA, onabotulinumtoxinA; SD, standard deviation; U, units.
aFollow up for 1st onabotA injection visit is calculated from index date; follow up for 2nd, 3rd, and 4th onabotA injection visit is calculated from 1st, 2nd and 3rd onabotA injection visits, respectively.